1. Home
  2. TGL vs PHGE Comparison

TGL vs PHGE Comparison

Compare TGL & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TGL

Treasure Global Inc.

HOLD

Current Price

$4.02

Market Cap

7.2M

Sector

Technology

ML Signal

HOLD

Logo BiomX Inc. COmmon Stock

PHGE

BiomX Inc. COmmon Stock

HOLD

Current Price

$0.72

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGL
PHGE
Founded
2020
2015
Country
United States
United States
Employees
N/A
57
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
5.9M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
TGL
PHGE
Price
$4.02
$0.72
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
16.1K
5.9M
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,330,557.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.25
52 Week High
$58.00
$8.50

Technical Indicators

Market Signals
Indicator
TGL
PHGE
Relative Strength Index (RSI) 45.43 36.26
Support Level $3.40 $0.48
Resistance Level $4.30 $2.35
Average True Range (ATR) 0.33 0.10
MACD -0.06 0.12
Stochastic Oscillator 23.17 89.69

Price Performance

Historical Comparison
TGL
PHGE

About TGL Treasure Global Inc.

Treasure Global Inc has created an online-to-offline e-commerce platform business model that offers consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retail or merchant settings. Its product is an internet application branded as the ZCITY app, which targets consumers by providing personalized deals based on their purchase history, location, and preferences. The Company has two reportable segments: payment processing and e-commerce operation in its ZCITY platform, and customized software development service, and the majority of revenue comes from payment processing and e-commerce operation in its ZCITY platform.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: